10.1096/fj.06-7407com FASEB J
Professional Supervision and Individual Assessment Before initiating any treatment, Performance Hyperbaric conducts a thorough assessment to determine suitability and tailor the therapy to individual health profiles
Patients should be reassured that gastrointestinal symptoms often improve with continued therapy as tolerance develops
Does not contain: Sugar, starch, yeast, wheat, soy, gluten, dairy products, preservatives, sweeteners, artificial flavours or colours.
The bad news is that rushing the titration will almost certainly result in more severe symptoms than either compound would cause alone
Phase 3 clinical trial data showed average weight loss of 28.7% of body weight (approximately 71.2 pounds) at the 12 mg dose over 68 weeks